A Phase 3 study comparing weekly insulin icodec to daily insulin glargine in Type 1 diabetes

Recruiting Phase 3 NCT07076199

Study Description

Weekly vs Daily Long-Acting Insulin Study for Adults with Type 1 Diabetes

Study Details

Registry ID:
NCT07076199
Conditions:
Diabetes Mellitus, Type 1
Phase:
Phase 3
Target Enrollment:
877 participants
Start Date:
Healthy Volunteers:
No

Study Locations (185 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →